Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00805259 · ClinicalTrials.gov registry record · NA

Promoting Mental Acuity in Elderly Populations Through Incentive for Technology Use

A NA study, sponsored by Carnegie Mellon University.

Completed
Registry status
NA
Development phase
312
Enrollment target

NCT00805259 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 312 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00805259, a NA study, has completed, sponsored by Carnegie Mellon University.

COMPLETED
Registry status
NA
Development phase
312 participants
Enrollment target

Study Summary

In this between-subject randomized controlled trial the investigators will test the impact of three novel structured financial incentives: atomistic, altruistic and team-based. These incentive schemes will be used to motivate one month of daily use of software designed to improve cognitive function (including memory, reaction times, attention and executive function) among the elderly. The 400 participants will be members of retirement communities in Pennsylvania. Three outcomes will be monitored and analyzed: activities completed using the software (primary), performance on the activities, and changes in cognitive functioning. This study is designed to be a pilot study. The investigators will have 90% power to find a mean daily difference of 4 activities completed in the control group versus 7 activities completed in the incentive groups assuming a standard deviation of 3.5 and an alpha of 0.017 (the bonferroni corrected significance level to account for multiple comparisons). In addition during a three month "follow-up period" all participants will have continued access to the software, however, no incentives will be provided for use. This period will be used to assess the impact of the initial incentives on long run use after financial incentives have ceased.

Interventions

  • BEHAVIORAL Financial incentives

Trial Details

FieldValue
Enrollment Target 312 participants
Start Date 2010-08
Est. Completion 2011-05
Phase NA

Sponsor

Carnegie Mellon University

37 total trials

What the Registry Record Tells You About NCT00805259

The ClinicalTrials.gov registry entry for NCT00805259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Financial incentives is the first listed.

NCT00805259 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00805259 about?

NCT00805259 is a clinical study titled "Promoting Mental Acuity in Elderly Populations Through Incentive for Technology Use". In this between-subject randomized controlled trial the investigators will test the impact of three novel structured financial incentives: atomistic, altruistic and team-based. These incentive schemes will be used to motivate one month of daily use of software designed to improve cognitive function ...

What is the current status of trial NCT00805259?

This trial is currently completed. It is a NA study. The enrollment target is 312 participants. The study started on 2010-08. Estimated completion is 2011-05.

What interventions are being tested in trial NCT00805259?

The interventions under investigation include: Financial incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT00805259?

This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.